Drugs / PCV7
PCV7
also known as
Prevnar · 7-valent pneumococcal conjugate vaccine · 7vPnc · Pneumococcal 7-valent Conjugate Vaccine
Trials 4
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT00153543 | May 2002 → Jun 2003 | pneumococcal infection | Centers for Disease Control and Prevention | Completed | No outcome recorded |
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT00169234 | May 2003 → Feb 2005 | pneumonia | Kaiser Permanente | Completed | No outcome recorded |
| Phase 31 trial · 1 met primary | ||||||
| Phase 3 | NCT00189020 | Jun 2005 → Feb 2008 | pneumococcal infection | UMC Utrecht | Completed | Met primary |
| Phase not applicable1 trial | ||||||
| — | NCT02133469 | Jun 2012 → Apr 2014 | nasopharyngeal disorder, streptococcal pneumonia | Centers for Disease Control and Prevention, China | Completed | No outcome recorded |
| Comparator or background therapy3 trials | ||||||
| Phase 3 | NCT00617760 Comparator | Mar 2008 → Aug 2009 | meningococcal meningitis, pneumococcal infection | Pfizer | Completed | No outcome recorded |
| Phase 3 | NCT00667602 Background | Mar 2008 → Jul 2009 | meningococcal meningitis | Novartis Vaccines | Completed | No outcome recorded |
| Phase 3 | NCT00373958 Comparator | Sep 2006 → Jun 2008 | — | Pfizer | Completed | No outcome recorded |
Evidence & citations 7 cited values
Every value below carries the sentence it was read from. 9 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PCV-7 | “7-Valent pneumococcal conjugate vaccine (PCV7 [Prevnar, Wyeth Pharmaceuticals Inc, Philadelphia, PA], serotypes 4, 6B, 9V, 14, 18C, 19F, and 23F) is effective in preventing...” PMID 20732948 ↗ Aug 20108“Seven-valent pneumococcal conjugate vaccine (PCV-7) is effective against vaccine serotype disease and carriage.” PMID 24447437 ↗ Feb 2014 “A 7-valent pneumococcal conjugate vaccine (PCV-7) was licensed in 2000 (Prevnar™, Wyeth Lederle Vaccines)” NCT00153543 ↗ |
| Known as | 7-valent pneumococcal conjugate vaccine | “A 7-valent pneumococcal conjugate vaccine (PCV-7) was licensed in 2000 (Prevnar™, Wyeth Lederle Vaccines)” NCT00153543 ↗ |
| Known as | 7vPnc | “The purpose of this study is to evaluate the safety, tolerability, and immunogenicity of the 13-valent pneumococcal vaccine (13vPnC) compare to the 7-valent pneumococcal...” NCT00373958 ↗ |
| Known as | Pneumococcal 7-valent Conjugate Vaccine | “One 0.5mL dose of Pneumococcal 7-valent Conjugate Vaccine (PCV7) was administered by intramuscular injection.” NCT00667602 ↗ |
| Known as | Prevnar | “7-Valent pneumococcal conjugate vaccine (PCV7 [Prevnar, Wyeth Pharmaceuticals Inc, Philadelphia, PA], serotypes 4, 6B, 9V, 14, 18C, 19F, and 23F) is effective in preventing...” PMID 20732948 ↗ Aug 20102“A 7-valent pneumococcal conjugate vaccine (PCV-7) was licensed in 2000 (Prevnar™, Wyeth Lederle Vaccines)” NCT00153543 ↗ “Biological: PCV7, Prevnar®” NCT00169234 ↗ |
| Modality | Vaccine | “7-valent pneumococcal conjugate vaccine” NCT00153543 ↗ |
| Route | Intramuscular | “PCV7 (0.5 ml) to be administered in the right thigh muscle” NCT00617760 ↗ |